Skip to main content

toppbild-press-1551x278.jpg

Press

Interview with CEO Anna Ljung

Link to video »
  • All pressreleases
  • Regulatory
2024-05-07 | Press release
Moberg Pharma´s interim report January - March 2024
2024-05-06 | Press release
National approval for MOB-015 in all 13 countries
2024-04-23 | Press release
Launch update for MOB-015

Read more »

2024-05-07 | Press release
Moberg Pharma´s interim report January - March 2024
2024-04-12 | Press release
Notice of Annual General Meeting in Moberg Pharma AB (publ)
2024-04-12 | Press release
Moberg Pharma Annual report for 2023

Read more press releases »

Latest report

2024-05-07 Moberg Pharma´s interim report January - March 2024

Contact for press och media:

Anna Ljung, CEO
Phone: +46 8 522 307 08
Email: anna.ljung@mobergpharma.se
 

Subscribe

Get our latest press releases and reports

 

Calendar/presentations

Next calendar event: 2024-05-14 Annual General Meeting of Moberg Pharma

IMAGE BANK  »